Von Willebrand Factor Levels in Patients With Liver Cirrhosis and Portal Hypertension
NCT06694090 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 67
Last updated 2024-11-19
Summary
Verify Von willebrand factor role in patients with liver cirrhosis and portal hypertension
Conditions
- Liver Cirrhosis
- Portal Hypertension
Sponsors & Collaborators
-
Assiut University
lead OTHER
Principal Investigators
-
Kerolos A Sameh, Resident · Assiut University
-
Mohamed A Ramadan, Lecturer · Assiut University
-
Abdelhamid A Mohamed, Lecturer · Assiut University
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-11-15
- Primary Completion
- 2025-11-15
- Completion
- 2025-12-15
More Related Trials
-
ADAMTS-13 and Von Willebrand Factor Levels and Activities in Children With Cirrhosis and/or Portal Hypertension
NCT04267406 ·Status: COMPLETED
-
Diagnosis of Variceal Bleeding and Its Control in Cirrhosis
NCT00188097 ·Status: TERMINATED ·Phase: NA
-
Effect of Variceal Eradication on Portal Circulation
NCT04538209 ·Status: UNKNOWN
-
Anticoagulation for Non-occlusive Portal Vein Thrombosis in Patients With Liver Cirrhosis
NCT02526303 ·Status: WITHDRAWN ·Phase: NA
-
Prevalence and Predictive Factors of Portal Vein Thrombosis in Patients With Cirrhosis
NCT02069457 ·Status: COMPLETED
-
Portal Vein Flow Velocity as a Screening Tool for Oesophageal Varices in Cirrhotic Patients
NCT05228509 ·Status: RECRUITING
-
Hepatic Manifestations and Effect of Long COVID-19 on Patients With Chronic Liver Disease
NCT04998214 ·Status: UNKNOWN
-
Effects of Platelet Mimicking Nanoparticles in Patients With Cirrhosis
NCT06050993 ·Status: COMPLETED
-
Vienna Vascular Liver Disease Study
NCT03541057 ·Status: RECRUITING
-
Patients' Outcome With Severe or Fulminant Hepatic Insufficiency, Hospitalized in the Public Hospitals of Paris
NCT04658407 ·Status: UNKNOWN
-
Platelet Indices in Decompensated Post Hepatitic Liver Cirrhosis
NCT04126447 ·Status: UNKNOWN
-
Effect of Antiviral Therapy on HVPG in Patients With Viral Cirrhosis
NCT04797910 ·Status: UNKNOWN
-
Portal Vein Thrombosis in Cirrhosis
NCT02275585 ·Status: WITHDRAWN
-
Effect of Portal Vein Thrombosis on the Prognosis of Liver Cirrhosis
NCT02335580 ·Status: COMPLETED
-
Efficacy and Safety of Intravenous Vitamin K1 in Management of Acute Variceal Bleeding
NCT06839352 ·Status: COMPLETED ·Phase: PHASE4
-
Noninvasive Prediction of Portal Hypertension in Cirrhosis Using Sound Touch Viscoelastography
NCT06316869 ·Status: NOT_YET_RECRUITING
-
Correlation of Platelets Count With Endoscopic Findings in a Cohort of Egyptian Patients With Liver Cirrhosis
NCT02621372 ·Status: UNKNOWN
-
Portal Hypertension and Systemic Endothelial Function
NCT02850692 ·Status: UNKNOWN ·Phase: NA
-
Non-invasive Method for Predicting the Presence of Gastroesophageal Varices in Patients With Cirrhosis
NCT04123509 ·Status: UNKNOWN
-
Albumin Bilirubin Index as a Predictor of Outcome of Variceal Bleeding
NCT06614114 ·Status: RECRUITING
-
Efficacy & Safety of Anticoagulants in Cirrhosis ± HCC
NCT07132515 ·Status: RECRUITING ·Phase: PHASE4
-
To Study the Role of Plasma Von Willebrand Factor Antigen (vWF) to A Disintegrin-like and Metalloproteinase With Thrombospondin Type-1 Motifs 13 (ADAMTS-13) Activity Ratio as a Predictor of Development of Extrahepatic Organ Failure in Acute on Chronic Liver Failure (ACLF) Patients.
NCT06066814 ·Status: UNKNOWN
-
Pattern and Short Term Outcomes of Renal Affection in Patients With Liver Cirrhosis in Al-Rajhi Liver Hospital
NCT06924294 ·Status: NOT_YET_RECRUITING
-
Renal Function Determination in Patients With Liver Cirrhosis
NCT02047240 ·Status: COMPLETED
-
Effect of Non-alcoholic Fatty Liver Disease on Kidney Functions
NCT03172650 ·Status: UNKNOWN